oxacillin has been researched along with Disease Models, Animal in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (27.59) | 18.7374 |
| 1990's | 4 (13.79) | 18.2507 |
| 2000's | 7 (24.14) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fein, M; Kong, L; Oluola, O; Weisman, LE | 1 |
| Giamarellou, H; Kyroudi, A; Papalois, A; Pefanis, A; Skiadas, I; Triantafyllidi, H; Tsaganos, T | 1 |
| Bhakta, S; Boshoff, HI; Evangelopoulos, D; Gibbons, S; Gunaratnam, M; Lenaerts, A; Malkinson, JP; Moreira, JB; Neidle, S; O'Donnell, G; Poeschl, R; Zimhony, O | 1 |
| Channabasappa, S; Chikkamadaiah, R; Desai, S; Durgaiah, M; Hiremath, D; Kumar, S; Mohan, T; Nair, S; Poonacha, N; Sharma, U; Tuppad, D; Vipra, A | 1 |
| Hertlein, T; Jakob, P; Lorenz, U; Ohlsen, K; Sturm, V; Sumathy, K | 1 |
| Chang, M; Ding, D; Janardhanan, J; Meisel, JE; Mobashery, S; Schroeder, VA; Wolter, WR | 1 |
| Adkins, JN; Black, NS; Clair, GC; Coughlan, S; Downing, T; Gore, S; Kadioglu, A; O'Gara, JP; O'Neill, E; Rudkin, JK; Waters, EM; Xia, G | 1 |
| Ishii, M; Matsumoto, Y; Moriya, K; Okazaki, M; Sato, T; Sekimizu, K; Tabuchi, F; Tatsuno, K | 1 |
| Azevedo, ÍM; Carriço, AD; Carvalho, JF; Medeiros, AC; Rocha, KB | 1 |
| Bayer, AS; Cheung, AL; Memmi, G; Trotonda, MP; Xiong, YQ | 1 |
| Blick, SK; Lyseng-Williamson, KA | 1 |
| Chahales, P; Collin, M; Daniel, A; Euler, C; Fischetti, VA; Gorelick, KJ | 1 |
| Agudelo, M; Rodriguez, CA; Vesga, O; Zuluaga, AF | 1 |
| Bayer, AS; Boyle-Vavra, S; Daum, R; Jones, T; Xiong, YQ; Yang, SJ | 1 |
| Bierry, G; Dietemann, JL; Ehlinger, M; Jehl, F; Lefevre, S; Neuville, A; Robert, P; Ruimy, D; Sordet, C | 1 |
| Bates, DM; Bayer, AS; McNamara, PJ; Peters, G; Proctor, RA; von Eiff, C; Yeaman, MR | 1 |
| Krogstad, DJ; Marsh, JL; Smith, GL; Stevens, WG | 1 |
| Murray, TW; Sande, MA; Strausbaugh, LJ | 1 |
| Alekhova, TM; Belozub, EA; Iaremenko, AI; Lobanov, SA | 1 |
| Bayer, AS; Ing, M; Li, C | 1 |
| Bayer, AS; Dhawan, VK; Yeaman, MR | 1 |
| Abrutyn, E; Lane, TW | 1 |
| Auckenthaler, R; Chuard, C; Herrmann, M; Lew, DP; Lucet, JC; Rohner, P; Waldvogel, FA | 1 |
| Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
| Allison, MJ; Dalton, HP; Escobar, MR; Muhovich, M | 1 |
| Campos, ME; Rabinovich, S; Smith, IM | 1 |
| Berezina, EK; Chavdarova, VB; Navashin, SM; Petrova, MA | 1 |
| Poliak, MS | 1 |
| Biró, L; Iván, E | 1 |
29 other study(ies) available for oxacillin and Disease Models, Animal
| Article | Year |
|---|---|
Lysostaphin in treatment of neonatal Staphylococcus aureus infection.
Topics: Animals; Animals, Suckling; Anti-Infective Agents, Local; Disease Models, Animal; Humans; Infant, Newborn; Lysostaphin; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.
Topics: Adjuvants, Immunologic; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Aortic Valve; Aza Compounds; Dexamethasone; Disease Models, Animal; Echocardiography; Endocarditis, Bacterial; Fluoroquinolones; Humans; Methicillin; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Bioactive pyridine-N-oxide disulfides from Allium stipitatum.
Topics: 2,2'-Dipyridyl; Alkaloids; Allium; Animals; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Disulfides; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Heat-Shock Proteins; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Molecular Structure; Oxyquinoline; Pyridines; Thioredoxins; Vitamin K 3 | 2009 |
Restoration of sensitivity of a diverse set of drug-resistant Staphylococcus clinical strains by bactericidal protein P128.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Oxacillin; Recombinant Fusion Proteins; Staphylococcal Infections; Staphylococcus aureus | 2018 |
Bioluminescence and 19F magnetic resonance imaging visualize the efficacy of lysostaphin alone and in combination with oxacillin against Staphylococcus aureus in murine thigh and catheter-associated infection models.
Topics: Animals; Anti-Bacterial Agents; Catheter-Related Infections; Disease Models, Animal; Drug Therapy, Combination; Female; Fluorine Radioisotopes; Luminescent Measurements; Lysostaphin; Magnetic Resonance Imaging; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Thigh | 2014 |
In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Disease Models, Animal; Drug Synergism; Female; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxacillin; Oxadiazoles; Staphylococcal Infections | 2016 |
Redeploying β-Lactam Antibiotics as a Novel Antivirulence Strategy for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Disease Models, Animal; Gene Expression Regulation, Bacterial; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Oxacillin; Pneumonia, Staphylococcal; Quorum Sensing; Sepsis; Staphylococcal Infections; Virulence | 2017 |
Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Bombyx; Ceftriaxone; Disease Models, Animal; Drug Synergism; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2017 |
Oxacillin magnetically targeted for the treatment of Methicillin-Resistant S. aureus infection in rats.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Magnetite Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Nanoparticles; Oxacillin; Random Allocation; Rats; Rats, Wistar; Staphylococcal Infections | 2017 |
Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacteriolysis; Cell Wall; Community-Acquired Infections; Disease Models, Animal; Drug Resistance, Bacterial; Endocarditis, Bacterial; Gene Expression Regulation, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; N-Acetylmuramoyl-L-alanine Amidase; Oxacillin; Rabbits; Staphylococcal Infections; Trans-Activators; Vancomycin | 2009 |
Telavancin.
Topics: Adult; Aminoglycosides; Animals; Anti-Bacterial Agents; Cross Infection; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Skin Diseases, Infectious; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Base Sequence; Disease Models, Animal; DNA Primers; DNA, Viral; Drug Synergism; Female; Genes, Viral; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Oxacillin; Protein Engineering; Recombinant Fusion Proteins; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus Phages; Vancomycin; Viral Proteins | 2010 |
In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drugs, Generic; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Microbial Viability; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2010 |
Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect").
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Rabbits; Treatment Outcome | 2010 |
Septic arthritis: monitoring with USPIO-enhanced macrophage MR imaging.
Topics: Animals; Arthritis, Infectious; Contrast Media; Daptomycin; Dextrans; Disease Models, Animal; Female; Knee Joint; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Oxacillin; Prospective Studies; Rabbits | 2011 |
Staphylococcus aureus menD and hemB mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney.
Topics: Animals; Blood Proteins; Disease Models, Animal; Drug Resistance, Bacterial; Endocarditis, Bacterial; Female; Genes, Bacterial; Kidney; Male; Microbial Sensitivity Tests; Mutation; Oxacillin; Penicillins; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vitamin K 3 | 2003 |
Reinsertability after breast prosthesis pocket infection: an experimental study.
Topics: Animals; Breast; Disease Models, Animal; Infusions, Parenteral; Male; Oxacillin; Postoperative Complications; Prostheses and Implants; Rats; Rats, Inbred Strains; Reoperation; Staphylococcal Infections; Surgical Wound Infection; Therapeutic Irrigation; Time Factors | 1982 |
Comparative penetration of six antibiotics into the cerebrospinal fluid of rabbits with experimental staphylococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Cephradine; Disease Models, Animal; Leukocyte Count; Male; Meningitis; Methicillin; Nafcillin; Oxacillin; Rabbits; Staphylococcal Infections; Vancomycin | 1980 |
[The experimental evaluation of the efficacy of using a Rhodiola rosea extract for treating odontogenic inflammatory diseases].
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Escherichia coli; Focal Infection, Dental; Male; Microbial Sensitivity Tests; Oxacillin; Penicillin G Benzathine; Penicillins; Plant Extracts; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus | 1996 |
Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.
Topics: Animals; Anti-Infective Agents; Disease Models, Animal; Endocarditis, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Oxacillin; Penicillins; Rabbits; Staphylococcal Infections; Staphylococcus | 1998 |
Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis.
Topics: Animals; Anti-Bacterial Agents; Blood Proteins; Disease Models, Animal; Endocarditis, Bacterial; Microbial Sensitivity Tests; Oxacillin; Penicillins; Phenotype; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2000 |
Induction and prevention of experimental arteriovenous fistula infections.
Topics: Animals; Arteriovenous Fistula; Disease Models, Animal; Oxacillin; Rabbits; Staphylococcal Infections; Vancomycin | 1979 |
Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Diffusion Chambers, Culture; Disease Models, Animal; Drug Resistance, Microbial; Fleroxacin; Foreign Bodies; Gentamicins; Kinetics; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1991 |
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Cephalothin; Daptomycin; Disease Models, Animal; Female; Glycopeptides; Oxacillin; Peptides; Rabbits; Staphylococcal Infections; Sulbactam; Teicoplanin; Vancomycin | 1990 |
Pulmonary infection due to disruption of the pharyngeal bacterial flora by antibiotics in hamsters.
Topics: Animals; Bacillus; Bacteria; Bacteriological Techniques; Bronchopneumonia; Corynebacterium; Cricetinae; Disease Models, Animal; Enterobacteriaceae; Escherichia coli; Female; Klebsiella; Klebsiella pneumoniae; Lung; Male; Neisseria; Oxacillin; Pharynx; Pneumonia; Proteus mirabilis; Staphylococcus; Streptococcus | 1974 |
Therapy of experimental staphylococcal infection with antibiotic combinations.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Disease Models, Animal; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Gentamicins; Lincomycin; Mice; Oxacillin; Staphylococcal Infections; Vancomycin | 1974 |
[Combined experimental use of polysynthetic penicillins].
Topics: Ampicillin; Animals; Blood; Depression, Chemical; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Kidney; Liver; Lung; Mice; Myocardium; Oxacillin; Penicillin Resistance; Penicillinase; Spleen; Staphylococcal Infections; Staphylococcus | 1970 |
[Effectiveness of polysynthetic penicillins in experimental anaerobic (gaseous) infection].
Topics: Ampicillin; Animals; Clostridium Infections; Disease Models, Animal; Drug Synergism; In Vitro Techniques; Injections, Intramuscular; Injections, Intravenous; Methicillin; Methods; Mice; Oxacillin; Penicillin Resistance; Penicillins | 1971 |
Study of bactericidal and bacteriostatic antibiotics in experimentally diabetic and senescent mice, in cases of lethal staphylococcal infection.
Topics: Aging; Animals; Diabetes Mellitus; Disease Models, Animal; Erythromycin; Immunosuppression Therapy; Male; Mice; Neomycin; Oxacillin; Staphylococcal Infections | 1971 |